Tscan Therapeutics, Inc.
Clinical trials sponsored by Tscan Therapeutics, Inc., explained in plain language.
-
15-Year safety check for experimental cancer therapy
Knowledge-focused Recruiting nowThis study monitors up to 1,000 people who previously received an experimental T-cell therapy (TSC-100 or TSC-101) for certain blood cancers. Researchers will track side effects and survival for 15 years to understand the long-term safety and effectiveness of the treatment. No ne…
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC
-
Scientists hunt for hidden triggers in autoimmune diseases
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 300 people with autoimmune diseases like Crohn's, multiple sclerosis, and celiac disease. Researchers will identify which T-cells are attacking the body and what they target. The goal is to discover new targets for future treatmen…
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC